Prosecution Insights
Last updated: April 19, 2026

Kolon Tissuegene Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
3
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17543911 COMPOSITION FOR TREATING INFLAMMATORY DISEASE INDUCED BY HYPERIMMUNE RESPONSE REGLAS, GILLIAN CHELSEA 1632 Final Rejection Dec 07, 2021
17488779 MIXED-CELL GENE THERAPY VAN BUREN, LAUREN K 1638 Final Rejection Sep 29, 2021
17488785 CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-BETA WESTON, ALYSSA G 1633 Final Rejection Sep 29, 2021

Managing Kolon Tissuegene Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month